Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-19

Clinical Trial Update: Stem Cells for Erectile Dysfunction Post RALP [Phase 1, Phase 2]

View source ↗

Summary

A stem cell therapy trial for erectile dysfunction after radical prostatectomy is in Phase 1/2 and not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Stem Cell Therapy for Erectile Dysfunction (Stem cells)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Erectile Dysfunction, Prostate Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING